|
|
||||||||
Articles |
1
Institute for Molecular and Human Genetics, Georgetown University Medical Center, Washington, DC 20007.
2
Division of Medical Genetics, Children's Hospital Los
Angeles, and Department of Pediatrics, University of Southern
California, School of Medicine, Los Angeles, CA 90027.
a Address correspondence to this author at: Institute for Molecular and Human Genetics, 3800 Reservoir Rd. NW, Suite 4000, Georgetown University Medical Center, Washington, DC 20007. Fax 202-784-1770; e-mail wonglj{at}gunet.georgetown.edu
Background: A unique requirement for the molecular diagnosis of mitochondrial DNA (mtDNA) disorders is the ability to detect heteroplasmic mtDNA mutations and to distinguish them from homoplasmic sequence variations before further testing (e.g., sequencing) is performed. We evaluated the potential utility of temporal temperature gradient gel electrophoresis (TTGE) for these purposes in patients with suspected mtDNA mutations.
Methods: DNA samples were selected from patients with known mtDNA mutations and patients suspected of mtDNA disorders without detectable mutations by routine analysis. Six regions of mtDNA were PCR amplified and analyzed by TTGE. Electrophoresis was carried out at 145 V with a constant temperature increment of 1.2 °C/h. Mutations were identified by direct sequencing of the PCR products and confirmed by PCR/allele-specific oligonucleotide or PCR/restriction fragment length polymorphism analysis.
Results: In the experiments using patient samples containing
various amounts of mutant mtDNA, TTGE detected as little as 4% mutant
heteroplasmy and identified heteroplasmy in the presence of a
homoplasmic polymorphism. In 109 specimens with 15 different known
mutations, TTGE detected the presence of all mutations and
distinguished heteroplasmic mutations from homoplasmic polymorphisms.
When 11% of the mtDNA genome was analyzed by TTGE in 104 patients with
clinically suspected mitochondrial disorders, 7 cases of heteroplasmy
(
7%) were detected.
Conclusions: TTGE distinguishes heteroplasmic mutation from homoplasmic polymorphisms and appears to be a sensitive tool for detection of sequence variations and heteroplasmy in patients suspected of having mtDNA disorders.© 1999 American Association for Clinical Chemistry
The following articles in journals at HighWire Press have cited this article:
![]() |
K. S. Lim, R. K. Naviaux, and R. H. Haas Quantitative Mitochondrial DNA Mutation Analysis by Denaturing HPLC Clin. Chem., June 1, 2007; 53(6): 1046 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
L-J C Wong, D Yim, R-K Bai, H Kwon, M M Vacek, J Zane, C L Hoppel, and D S Kerr A novel mutation in the mitochondrial tRNASer(AGY) gene associated with mitochondrial myopathy, encephalopathy, and complex I deficiency. J. Med. Genet., September 1, 2006; 43(9): e46 - e46. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-K. Bai and L.-J. C. Wong Simultaneous Detection and Quantification of Mitochondrial DNA Deletion(s), Depletion, and Over-Replication in Patients with Mitochondrial Disease J. Mol. Diagn., November 1, 2005; 7(5): 613 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Girald-Rosa, R. A. Vleugels, A. C. Musiek, and J. E. Sligh High-Throughput Mitochondrial Genome Screening Method for Nonmelanoma Skin Cancer Using Multiplexed Temperature Gradient Capillary Electrophoresis Clin. Chem., February 1, 2005; 51(2): 305 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhu, W. Qin, P. Bradley, A. Wessel, C. L. Puckett, and E. R. Sauter Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid Carcinogenesis, January 1, 2005; 26(1): 145 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kurtz, M. Lueth, L. Kluwe, T. Zhang, R. Foster, V.-F. Mautner, M. Hartmann, D.-J. Tan, R. L. Martuza, R. E. Friedrich, et al. Somatic Mitochondrial DNA Mutations in Neurofibromatosis Type 1-Associated Tumors Mol. Cancer Res., August 1, 2004; 2(8): 433 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
L-J C Wong, D-J Tan, R-K Bai, K-T Yeh, and J Chang Molecular alterations in mitochondrial DNA of hepatocellular carcinomas: is there a correlation with clinicopathological profile? J. Med. Genet., May 1, 2004; 41(5): e65 - e65. [Full Text] [PDF] |
||||
![]() |
L.-J. C. Wong, M. Lueth, X.-N. Li, C. C. Lau, and H. Vogel Detection of Mitochondrial DNA Mutations in the Tumor and Cerebrospinal Fluid of Medulloblastoma Patients Cancer Res., July 15, 2003; 63(14): 3866 - 3871. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Shaji, E. S. Edison, B. Poonkuzhali, A. Srivastava, and M. Chandy Rapid Detection of {beta}-Globin Gene Mutations and Polymorphisms by Temporal Temperature Gradient Gel Electrophoresis Clin. Chem., May 1, 2003; 49(5): 777 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Boles, D. Chaudhari, J. Soderkvist, M. Podberezin, and M. Ito Quantification of Mitochondrial DNA Heteroplasmy by Temporal Temperature Gradient Gel Electrophoresis Clin. Chem., January 1, 2003; 49(1): 198 - 200. [Full Text] [PDF] |
||||
![]() |
L.-J. C. Wong, M.-H. Liang, H. Kwon, J. Park, R.-K. Bai, and D.-J. Tan Comprehensive Scanning of the Entire Mitochondrial Genome for Mutations Clin. Chem., November 1, 2002; 48(11): 1901 - 1912. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Bernard and C. T. Wittwer Real-Time PCR Technology for Cancer Diagnostics Clin. Chem., August 1, 2002; 48(8): 1178 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Millward, W. Samowitz, C. T. Wittwer, and P. S. Bernard Homogeneous Amplification and Mutation Scanning of the p53 Gene Using Fluorescent Melting Curves Clin. Chem., August 1, 2002; 48(8): 1321 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-J. Tan, R.-K. Bai, and L.-J. C. Wong Comprehensive Scanning of Somatic Mitochondrial DNA Mutations in Breast Cancer Cancer Res., February 1, 2002; 62(4): 972 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. WANG, M. C BOWMAN, E. HSU, K. WERTZ, and L.-J. C WONG A novel mutation in the CFTR gene correlates with severe clinical phenotype in seven Hispanic patients J. Med. Genet., March 1, 2000; 37(3): 215 - 218. [Full Text] |
||||
![]() |
W. D. Parker Jr The Other Genome Clin. Chem., August 1, 1999; 45(8): 1129 - 1130. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |